Machine Learning and Digital Biomarkers Can Detect Early Stages of Neurodegenerative Diseases
Open accessThe DOI matches its Crossref record; 131 of the 131 references it cites were found in a registry or an index.
Abstract
Neurodegenerative diseases (NDs) such as Alzheimer’s Disease (AD) and Parkinson’s Disease (PD) are devastating conditions that can develop without noticeable symptoms, causing irreversible damage to neurons before any signs become clinically evident. NDs are a major cause of disability and mortality worldwide. Currently, there are no cures or treatments to halt their progression. Therefore, the development of early detection methods is urgently needed to delay neuronal loss as soon as possible. Despite advancements in Medtech, the early diagnosis of NDs remains a challenge at the intersection of medical, IT, and regulatory fields. Thus, this review explores “digital biomarkers” (tools designed for remote neurocognitive data collection and AI analysis) as a potential solution. The review summarizes that recent studies combining AI with digital biomarkers suggest the possibility of identifying pre-symptomatic indicators of NDs. For instance, research utilizing convolutional neural networks for eye tracking has achieved significant diagnostic accuracies. ROC-AUC scores reached up to 0.88, indicating high model performance in differentiating between PD patients and healthy controls. Similarly, advancements in facial expression analysis through tools have demonstrated significant potential in detecting emotional changes in ND patients, with some models reaching an accuracy of 0.89 and a precision of 0.85. This review follows a structured approach to article selection, starting with a comprehensive database search and culminating in a rigorous quality assessment and meaning for NDs of the different methods. The process is visualized in 10 tables with 54 parameters describing different approaches and their consequences for understanding various mechanisms in ND changes. However, these methods also face challenges related to data accuracy and privacy concerns. To address these issues, this review proposes strategies that emphasize the need for rigorous validation and rapid integration into clinical practice. Such integration could transform ND diagnostics, making early detection tools more cost-effective and globally accessible. In conclusion, this review underscores the urgent need to incorporate validated digital health tools into mainstream medical practice. This integration could indicate a new era in the early diagnosis of neurodegenerative diseases, potentially altering the trajectory of these conditions for millions worldwide. Thus, by highlighting specific and statistically significant findings, this review demonstrates the current progress in this field and the potential impact of these advancements on the global management of NDs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Growing access to speech data through mobile platforms, telehealth, and ambient voice technology is accelerating progress in this domain.105,106”
From Review of Artificial Intelligence for Clinical Use in Alzheimer's Disease and Related Dementias (2026) · cites this paper as [106]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
On computable numbers, with an application to the entscheidungsproblem
Turing, A. M. (1937) · Proceedings of the London Mathematical Society · doi:10.1112/plms/s2-42.1.230 · Cited by 8,283
Hearing loss and cognitive decline in older adults
Lin, F. R., Yaffe, K., Xia, J., Xue, Q.-L., Harris, T. B., Purchase-Helzner, E., Satterfield, S., Ayonayon, H. N., Ferrucci, L., Simonsick, E. M., et al. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.1868 · Cited by 4,017
Pawlak, Z. (1991) · Springer eBooks · doi:10.1007/978-94-011-3534-4 · Cited by 3,040 · cited 1×
“Introduced by Pawlak (1982), the RST offers a framework for understanding how the brain processes complex visual information, despite the imprecise nature of concepts representing objects’ physical properties [114,115].”
BackgroundEye Tracking Methodology: Theory and Practice
Duchowski, A. T. (2003) · Springer eBooks · doi:10.1007/978-1-4471-3750-4 · Cited by 2,242
Openface 2.0: facial behavior analysis toolkit
Baltrusaitis, T., Zadeh, A., Lim, Y. C., & Morency, L.-P. (2018) · 2018 13th IEEE International Conference on Automatic Face & Gesture Recognition (FG 2018) · doi:10.1109/fg.2018.00019 · Cited by 1,861 · cited 1×
“Importantly, mature open-source projects like OpenFace provide state-of-the-art results for selected facial action unit (AU) recognition [54].”
BackgroundAlzheimer disease: Epidemiology, diagnostic criteria, risk factors and biomarkers
Reitz, C., & Mayeux, R. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.12.024 · Cited by 1,181
The SAGE Encyclopedia of Communication Research Methods
Allen, M. (2017) · doi:10.4135/9781483381411 · Cited by 1,103
The Parkinson Pandemic—A Call to Action
Dorsey, E. R., & Bloem, B. R. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2017.3299 · Cited by 1,091 · cited 1×
“This is due to a combination of factors, including an aging population, declining smoking rates, and increasing industrialization [11,12].”
BackgroundZadeh, L. A. (1999) · IEEE Transactions on Circuits and Systems I: Fundamental Theory and Applications · doi:10.1109/81.739259 · Cited by 1,039
Adult hippocampal neurogenesis and its role in Alzheimer’s disease
Mu, Y., & Gage, F. H. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-85 · Cited by 1,021 · cited 1×
“Changes in the hippocampus, including altered neurogenesis, are early events in AD and may worsen memory impairment [26].”
Background
Research works printed but not linked: 2
- 38. Bejani, M.; Luque-Buzo, E.; Gomez-García, J.; Burlaka-Petrash, A.; Grandas, F.; Godino-Llorente, J. Detection of Parkinson's Disease by Analysis of Smooth Pursuit Eye Movements and Machine Learning. Mov. Disord. 2023, 37 (Suppl. S2), S184-S185. Available online: https://www.mdsabstracts.org/abstract/detection-of-parkinsons-disease-by-analysis-of-smooth-pursuit- eye-movements-and-machine-learning/ (accessed on 21 December 2023).
- Pawlak, 1982, Rough sets, Int. J. Parallel Program., 11, 341
Cited by
Kale, M., Wankhede, N., Pawar, R., Ballal, S., Kumawat, R., Goswami, M., Khalid, M., Taksande, B., Upaganlawar, A., Umekar, M., et al. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102497 · Cited by 183
Dangi, R. R., Sharma, A., & Vageriya, V. (2024) · Public Health Nursing · doi:10.1111/phn.13500 · Cited by 125
“This tailored approach helps optimize therapeutic efficacy and minimize adverse effects, enhancing overall patient management (Bi et al. 2021; Chudzik, Śledzianowski, and Przybyszewski 2024; Vrahatis et al. 2023).”
Ezzdine, L. B., Dhahbi, W., Dergaa, I., Ceylan, H. İ., Guelmami, N., Saad, H. B., Chamari, K., Ștefănică, V., & Omri, A. E. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1502417 · Cited by 119
“This section explores how these technologies are revolutionizing the development of personalized physical and cognitive rehabilitation programs for individuals with neurodegenerative diseases (Chudzik et al., 2024; Dergaa and Chamari, 2024).”
Noh, M., Kwon, H. S., Kwon, M., Nahm, M., Jin, H. K., Bae, J., & Kim, S. H. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00867-4 · Cited by 97
“Moreover, predictive models that integrate clinical biomarkers, neuroimaging, and genomic risk profiles from AD, PD, and ALS cohorts further refine translational pipelines [401–403].”
Yu, J., Zhou, R., Liu, S., Zheng, J., Yan, H., Su, S., Chai, N., Segal, E., Jiang, C., Guo, K., et al. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.4c02619 · Cited by 66
Digital Twin Cognition: AI-Biomarker Integration in Biomimetic Neuropsychology
Gkintoni, E., & Halkiopoulos, C. (2025) · Biomimetics · doi:10.3390/biomimetics10100640 · Cited by 54
Gkintoni, E., Vassilopoulos, S. P., Νικολάου, Γ., & Vantarakis, A. (2025) · Brain Sciences · doi:10.3390/brainsci15060582 · Cited by 42
Eye Tracking in Parkinson’s Disease: A Review of Oculomotor Markers and Clinical Applications
Diotaiuti, P., Marotta, G., Siena, F. D., Vitiello, S., Prinzio, F. D., Rodio, A., Libero, T. D., Falese, L., & Mancone, S. (2025) · Brain Sciences · doi:10.3390/brainsci15040362 · Cited by 37
“The integration of eye-tracking data with artificial intelligence (AI) and machine learning algorithms has the potential to enhance diagnostic accuracy, facilitating personalized treatment approaches [10].”
Pei, J., Perumal, N. C., Meng, P., Long, Q., & Palanisamy, C. P. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102904 · Cited by 37
Mechanisms underlying cognitive impairment and management strategies in type 2 diabetes
Chen, X., Huang, Y., & Xiong, X. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1655768 · Cited by 39
Polvorinos-Fernández, C., Sigcha, L., Borzì, L., Olmo, G., Asensio, C., López, J. M., de Arcas, G., & Pavón, I. (2024) · Applied Sciences · doi:10.3390/app142210189 · Cited by 37
Epigenetic biomarkers in Alzheimer's disease: Diagnostic and prognostic relevance
Behl, T., Kyada, A., Roopashree, R., Nathiya, D., Arya, R., Kumar, M., Khalid, M., Gulati, M., Sachdeva, M., Fareed, M., et al. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102556 · Cited by 33
Fatima, G., Ashiquzzaman, A., Kim, S. S., Kim, Y. R., Kwon, H.-S., & Chung, E. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106877 · Cited by 30
Calderone, A., Latella, D., Fauci, E. L., Puleo, R., Sergi, A., Francesco, M. D., Mauro, M., Foti, A., Salemi, L., & Calabrò, R. S. (2025) · Biomedicines · doi:10.3390/biomedicines13092118 · Cited by 28
“Because AI models are trained directly on large, diverse sets of data, they can help reduce the subjective variability and interpretive bias that can be inherent in human judgment [158].”
Akram, A. S., Grezenko, H., Singh, P., Ahmed, M., Hassan, B. D., Anand, V. H., Elashry, A. R., Nazir, F., & Khan, R. (2024) · Cureus · doi:10.7759/cureus.61335 · Cited by 28
Lentzen, M., Vairavan, S., Muurling, M., Alepopoulos, V., Atreya, A., Boada, M., de Boer, C., Conde, P., Curcic, J., Frisoni, G. B., et al. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01675-0 · Cited by 24
“…through a noninvasive, cost-effective method for collecting data on various functional parameters and digital biomarkers, including movement patterns, sleep quality, gait parameters, social engagement, and cognitive function, providing a comprehensive view of an individual’s health status [11, 12].”
Zarei, O., moghaddam, M. T., & Vastegani, S. M. (2025) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2025.111667 · Cited by 23
Baluta, S., Suresh, V., Chmielowska, M., Smeesters, L., & Cabaj, J. (2026) · ACS Omega · doi:10.1021/acsomega.5c06072 · Cited by 23
Rudroff, T. (2025) · Brain Sciences · doi:10.3390/brainsci15050533 · Cited by 22
“Together, these complementary approaches provide a comprehensive digital profile and multidimensional view of fatigue manifestations across domains [7,24].”
Sadu, V. B., Bagam, S., Naved, M. I., Andluru, S. K. R., Ramineni, K., Alharbi, M. G., Sengan, S., & Moideen, R. K. (2025) · Scientific Reports · doi:10.1038/s41598-025-05888-z · Cited by 19
Future Care: Artificial Intelligence and the New Age of Digital Health
Shukla, G., Sinha, A., Gehlot, A., & Singh, R. (2025) · doi:10.55938/wlp.v2i6.306 · Cited by 17
Revolutionizing Early Diagnosis: The Role of Artificial Intelligence in Neurodegenerative Disorders
Pal, S., Kaushik, A., Goel, F., Pal, A., & Garg, V. K. (2025) · Journal of Advanced Scientific Research · doi:10.55218/jasr.2025160306 · Cited by 16
Ben-Jaafar, A., Sinha, A., Nkrumah-Boateng, P. A., Roy, S., Sanker, V., Mohamed, S., Sarfo-Adu, F., Ali, S. H., & Awuah, W. A. (2026) · Molecular Brain · doi:10.1186/s13041-026-01287-1 · Cited by 16
“Digital bio-marker platforms similarly offer opportunities to reduce diagnostic costs through remote monitoring and early detection, potentially making diagnostic access more equitable globally [170].”
Kršek, A., Schleicher, L. M. S., Jagodic, A., & Batičić, L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26189178 · Cited by 16
“The ultimate aim is to reach an even more precise diagnostic tool for timely intervention in diagnostics [230].”
Basha, S., Pranavi, K. S., CHATTOPADHYAY, A., Pai, A. R., & Mahato, K. K. (2026) · Neurobiology of Disease · doi:10.1016/j.nbd.2026.107307 · Cited by 14
Gordleeva, S., Grigorev, N., Николаевна, П. Е., Kurkin, S., Kazantsev, V., & Hramov, A. E. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102923 · Cited by 12
Ndumgouo, I. M. N., Chowdhury, M. Z. U., Andreescu, S., & Schuckers, S. (2025) · Biosensors · doi:10.3390/bios15110729 · Cited by 12
Krishnamoorthy, U. (2025) · Analytical Methods · doi:10.1039/d5ay01580d · Cited by 12
Wenzheng, H., Agyemang, E. F., Srivastav, S. K., Shaffer, J. G., & Kakraba, S. (2025) · JMIR Aging · doi:10.2196/70272 · Cited by 12
Strobel, J., Yousefzadeh‐Nowshahr, E., Deininger, K., Bohn, K. P., Arnim, C. A. F. V., Otto, M., Solbach, C., Anderl‐Straub, S., Polivka, D., Fissler, P., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12071460 · Cited by 11
The role of deep learning-based algorithms in retinal image processing: a review
Celik, C., & Yücedağ, İ. (2026) · Multimedia Tools and Applications · doi:10.1007/s11042-026-21181-1 · Cited by 10
Neuroimaging and machine learning in eating disorders: a systematic review
Monaco, F., Vignapiano, A., Gruttola, B. D., Landi, S., Panarello, E., Malvone, R., Palermo, S., Marenna, A., Collantoni, E., Celia, G., et al. (2025) · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity · doi:10.1007/s40519-025-01757-w · Cited by 9
“Machine learning approaches may also be applied to longitudinal neurocognitive data to characterize trajectories of cognitive recovery following nutritional rehabilitation, potentially identifying predictive markers of treatment response [48, 49].”
SATHISH, R., Muthukumar, R., Kumaran, K. M., & Murugan, S. P. (2026) · Scientific Reports · doi:10.1038/s41598-026-36895-3 · Cited by 9
A New Wrist-Worn Tool Supporting the Diagnosis of Parkinsonian Motor Syndromes
Battista, L., & Romaniello, A. (2024) · Sensors · doi:10.3390/s24061965 · Cited by 9
“…proposed solutions based on the use of Artificial Intelligence include convolutional neural networks for eye tracking and facial expression analysis [16], Machine Learning-assisted speech analysis [17], and deep learning models for various modalities such as brain analysis and motion symptoms [18].”
MethodMachine Learning Recognizes Stages of Parkinson’s Disease Using Magnetic Resonance Imaging
Chudzik, A. (2024) · Sensors · doi:10.3390/s24248152 · Cited by 9
“Despite these limitations, this research contributes to the body of evidence supporting the use of machine learning models for the early diagnosis and monitoring of PD [67,83].”
Self-citationAlasmari, F. F., Ahmad, A., Alsanea, S., Hammad, A. M., & Al-Qerem, W. A. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1592277 · Cited by 9
“Eye tracking techniques by using arti fi cial intelligence and machine learning helped to differentiate PD patients and normal individuals (Chudzik et al., 2024).”
BDNF biosensors for neurodegenerative disease
Saeed, T. N., Al‐Hussainy, A. F., Sanghvi, G. V., Ballal, S., Singh, A., Sabarivani, A., Mishra, S., Rizaev, J. A., Taher, S. G., Alwan, M., et al. (2025) · Clinica Chimica Acta · doi:10.1016/j.cca.2025.120412 · Cited by 9
Ianculescu, M., Băjenaru, L., Vasilevschi, A.-M., Gheorghe-Moisii, M., & GHEORGHE, C.-G. (2025) · Future Internet · doi:10.3390/fi17070320 · Cited by 9
Shi, Q., Hou, J., Peng, X., Xu, Z., Wang, Y., & Cao, D. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102943 · Cited by 8
Deciphering the role of neuropeptides as biomarkers for early diagnosis of Parkinson's disease
Thakur, J., & Godad, A. P. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.123376 · Cited by 8
Shathik, J. A., Raju, M. S., K, R. K. R., Sharma, D. A., Raghi, K. R., & Kurpatwar, B. P. (2025) · International Journal of Environmental Sciences · doi:10.64252/8dbg7v71 · Cited by 8
Velmurugan, S., Waheeda, S., Kulanthaivel, L., & Subbaraj, G. K. (2025) · World Academy of Sciences Journal · doi:10.3892/wasj.2025.403 · Cited by 8
A dual-model AI framework for Alzheimer’s disease diagnosis using clinical and MRI data
Ciftci, F., Ayanoğlu, K. Y. U., Nematzadeh, S., & Anka, F. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2025.1713062 · Cited by 7
Hou, C.-H., & Liu, Y. (2025) · Computers in Human Behavior · doi:10.1016/j.chb.2025.108604 · Cited by 7
Classification of Parkinson’s Disease Using Machine Learning with MoCA Response Dynamics
Chudzik, A., & Przybyszewski, A. W. (2024) · Applied Sciences · doi:10.3390/app14072979 · Cited by 7
Self-citationReview of Artificial Intelligence for Clinical Use in Alzheimer's Disease and Related Dementias
Breithaupt, A. G., Tang, A., Paolillo, E. W., Bibars, M., Johnson, E. C. B., Saloner, R., Possin, K. L., Windon, C. C., Hill-Jarrett, T. G., Giorgio, J., et al. (2026) · Seminars in Neurology · doi:10.1055/a-2744-9871 · Cited by 6
Abbasi, A. A., Jokhio, F., Norouziyan, F., & Moradikor, N. (2025) · NeuroMarkers. · doi:10.1016/j.neumar.2025.100150 · Cited by 6
Alam, P., Hasan, G. M., Mohammad, T., & Hassan, M. I. (2026) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2026.108973 · Cited by 6
Artificial intelligence in sleep medicine I: Diagnosis, treatment, care, and research
Sharafkhaneh, A., Hirshkowitz, M., Razjouyan, J., BaHammam, A. S., Leppänen, T., Shin, C., Korkalainen, H., & Penzel, T. (2026) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2026.102295 · Cited by 6
Zhao, J., Shi, C., Zhang, X., Ma, S., Sun, W., Tian, F., Wang, P., Li, J., Du, J., Zhao, X., et al. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1537841 · Cited by 5
Mbue, N. D., Tabei, F., Williams, K. C., & Olanrewaju, K. B. (2025) · Sensors · doi:10.3390/s25175476 · Cited by 5
“Real-time data collection: Wearables monitor heart rate, movement, sleep, and cognitive tasks [73,74].”
Coskuner‐Weber, O., Gentili, P. L., & Uversky, V. N. (2025) · Biophysical Reviews · doi:10.1007/s12551-025-01286-x · Cited by 5
“Molecular biology knowledge can help cognitive computing systems identify patterns and markers associated with cognitive disorders, such as Alzheimer’s disease, Parkinson’s disease, and multiple forms of dementia (Chudzik et al. 2024; Haripriyaa and Suthindhiran 2024).”
Ariaei, A., Talebi, S., Ashtiani, B. H., Hamblin, M. R., Langouri, M. A., & Ramezani, F. (2025) · Scientific Reports · doi:10.1038/s41598-025-25562-8 · Cited by 4
Tarnanas, I., Seixas, A. A., Wyss, M., Vlamos, P., & Çöltekin, A. (2026) · Frontiers in Digital Health · doi:10.3389/fdgth.2025.1727707 · Cited by 4
“…diagnosis, staging, prognosis, and monitoring (15), there is broad consensus and abundant evidence that the non-invasive digital biomarkers and AI based approaches (deep/machine learning, i.e., DL/ML) can enhance ADRD evaluations in clinical settings and support clinical trials [e.g., (16–18)].”
Nurhasan, A. A., & Kasprowski, P. (2026) · Applied Sciences · doi:10.3390/app16052548 · Cited by 4
Enhancing Early Diagnosis: Multimodal AI Approaches for Neurodegenerative Diseases
Swamy, A., & Agrawal, D. K. (2026) · Journal of Biotechnology and Biomedicine · doi:10.26502/jbb.2642-91280211 · Cited by 4
“…directly evaluated whether artificial intelligence (AI)-derived imaging or electrophysiological signatures can consistently outpace traditional biomarkers in predictive timelines, leaving a significant gap in understanding how these emerging technologies should be positioned clinically [14,15].”
InfluentialChandru, M., Abinesh, M., Ananth, M. S., Vashist, A., & Manickam, P. (2025) · Current Opinion in Biomedical Engineering · doi:10.1016/j.cobme.2025.100638 · Cited by 4
Park, S. G., Mun, S. B., Kim, Y. J., & Kim, K. G. (2025) · Scientific Reports · doi:10.1038/s41598-025-04065-6 · Cited by 4
Ko, H. J., Kim, J. S., Kim, W., Yun, B. H., Park, S., Kim, D. H., Kwon, U. J., Lim, S. K., Kim, B. R., Lee, J. H., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-14130-9 · Cited by 4
Transforming medical diagnosis: a comprehensive review of AI and ML technologies
Gaonkar, A., Rath, S., Rahini, S., Jain, M., Vaman, R. S., Das, A., Manal, S., Lamba, D. S., Kaur, P., YADAV, S., et al. (2025) · Evidence Public Health · doi:10.61505/evipubh.2025.1.1.10 · Cited by 4
Nishal, Z., Khan, S., & Kamran, B. (2025) · Cureus · doi:10.7759/cureus.89418 · Cited by 3
“This has generated intense interest in developing biomarkers capable of identifying these alterations at their earliest stages, especially in prodromal conditions such as mild cognitive impairment (MCI) and PD with MCI (PD-MCI) [3,4].”
Pomianek, M. J., Piszczek, M., Stawarz, P., & Kucharczyk-Drab, A. (2025) · Sensors · doi:10.3390/s25206460 · Cited by 3
“The analysis of subtle eye movements, such as saccades and fixations, can provide early insights into cognitive decline and disease progression [4,14].”
Vasilevschi, A.-M., Coman, C., Ianculescu, M., & Coman, O. A. (2025) · Future Internet · doi:10.3390/fi17120562 · Cited by 3
“Current computerized tools for monitoring neurodegenerative disorders, notably the NeuroPredict platform, focus primarily on monitoring cognitive, motor, and behavioral symptoms [15–17].”
AI-Enhanced Wearable Systems for Proactive Detection of Cognitive Decline in Elderly People
Yu, T., Li, M., Roosli, R., & Dong, D. (2026) · International Journal of Humanoid Robotics · doi:10.1142/s0219843626400086 · Cited by 3
Multimodal Deep Learning for Early Prediction of Neurodegenerative Diseases: A Comprehensive Review
Gouthami, P., & Krishnamoorthi, M. (2026) · International Conference on Image Processing and Capsule Networks (ICIPCN) · doi:10.1109/icipcn67432.2026.11438980 · Cited by 3
“The analysis of digital biomarkers in [7] indicated that wearable-sensors and behavioural data could aid in the early screening.”
Tan, J., Deng, X., Wu, C., 姚万林, Liao, J., Zheng, H., & Lian, C. (2026) · Journal of Medical Internet Research · doi:10.2196/89057 · Cited by 3
“Beyond classic motion sensors, modalities including eye tracking, plantar pressure, and voice analysis (eg, studies by Amato, Chudzik, and Tsakanikas [21,22,65]) are broadening the scope of single-modality PD feature extraction.”
Chudzik, A., Nowacki, J. P., & Przybyszewski, A. W. (2024) · Lecture notes in computer science · doi:10.1007/978-3-031-78166-7_13 · Cited by 3
Self-citationNavas-León, S., Sánchez-Martín, M., Tajadura‐Jiménez, A., Coster, L. D., Mas, M. D. L. M. B., & Morales, L. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-06583-z · Cited by 3
Comparative Analysis of Machine Learning Methods for Alzheimer’s Disease Diagnosis
Pourmahboubi, A., Arsalani, N., Tabrizchi, H., & Mosavi, A. A. (2025) · IEEE International Conference on Intelligent Engineering Systems (INES) · doi:10.1109/ines67149.2025.11078185 · Cited by 2
Melo, M. R. P., Adamatti, D. F., & de Aguiar, M. S. (2025) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2025.111022 · Cited by 2
Extracellular vesicles in neurological disorders: emerging roles and underlying molecular mechanisms
Mimi, M. A., & Hasan, M. M. (2025) · Exploration of neuroscience · doi:10.37349/en.2025.1006118 · Cited by 2
RetractedBhatia, N., Khan, M. M. U., Masih, D., & Srinivas, U. (2025) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-025-00318-w · Cited by 2
“Psychedelics such as psilocybin, DMT, and LSD have re-emerged as potential neurotherapeutic agents due to their capacity to promote synaptic remodeling and reduce neuroinflammatory signaling via 5-HT2A receptor modulation [ 169 – 171].”
Ganguly, B. B., & Kadam, N. N. (2025) · Gene Expression · doi:10.14218/ge.2025.00051 · Cited by 2
Partey-Newman, V., Baiden, I., Phil-Othihiwa, S. O., & Dudzilah, G. (2026) · doi:10.69739/jmhp.v1i1.1535 · Cited by 2
Loaiza, C. A. S., Rodríguez, P. E. V., Yarlequé, H. M. G. C., & Ruiz, J. V. G. (2026) · RECIAMUC · doi:10.26820/reciamuc/10.(1).oct.2026.167-189 · Cited by 2
Schneider, P., Mikołajewski, D., Bryniarska, A., Igraś-Cybulska, M., Cybulski, A., Marcinowicz, W., Janiszewski, M., & Kawala‐Sterniuk, A. (2024) · Progress in Applied Electrical Engineering (PAEE) · doi:10.1109/paee63906.2024.10701433 · Cited by 2
“Facial recognition software can detect micro-expressions and subtle changes in facial features to infer emotions accurately [21].”
BackgroundRavi, R., Sridevi, T. P., Devi, N. N., & Mandadi, S. (2024) · Advances in bioinformatics and biomedical engineering book series · doi:10.4018/979-8-3693-6442-0.ch001 · Cited by 2
Sagar, Y. A. (2024) · International Journal of Intelligent Systems and Applications in Engineering · Cited by 2
Immunoglobulin G4: Cross Talk in Hearing Loss Manifestation
Barfejani, A. H., & Ghobadi, A. (2025) · Indian Journal of Otology · doi:10.4103/indianjotol.indianjotol_204_24 · Cited by 1
Zhang, Y., Zhang, W., Li, G. L. G., Huang, J., Zou, H., Zhang, X., Wang, X., & Xiaoguang, L. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1794652 · Cited by 1
“…limitation (Kassavetis et al., 2022; Pinkhardt and Kassubek, 2011), as a potential digital biomarker for prodromal PD, eye tracking has been used to dierentiate PD from healthy individuals and to support early identification of disease-related changes (Chudzik et al., 2024; Tsitsi et al., 2021).”
Bastardo, R., Pavão, J., Martins, A. I., Silva, A. G., & Rocha, N. P. (2025) · Future Internet · doi:10.3390/fi17080376 · Cited by 1
Biomarkers: From early detection to treatment personalization
Fatima, S., Tiwari, S., Siddiqi, B., Quadri, S. N., & Abdin, M. Z. (2025) · Progress in brain research · doi:10.1016/bs.pbr.2025.08.008 · Cited by 1
Afzal, N., Iqbal, J., Waris, A., Khan, M. J., Hazzazi, F., Ali, H., Ijaz, M. A., & Gilani, S. O. (2025) · Frontiers in Computational Neuroscience · doi:10.3389/fncom.2025.1660963 · Cited by 1
Machine Learning-Based Multimodal Molecular Biomarkers for Predictive Health Analytics
George, M. L., Bandi, S. R., Dilip, K. G., Murugesan, S., Meenakshi, D., & Dixy, F. L. (2026) · Journal of Visualized Experiments · doi:10.3791/69241 · Cited by 1
Perna, P., Alessandra, C., Stasolla, F., & Nappo, R. (2026) · Technologies · doi:10.3390/technologies14030183 · Cited by 1
Olfactory bulb volume changes across Alzheimer’s disease stages
Ersoy, S., Yaşar, A. B., Ersoy, E. O., & Yılmaz, M. (2026) · Neurology Asia · doi:10.54029/2026mdm · Cited by 1
Gupta, D. K., & Chaudhuri, A. (2026) · Journal of Mental Health and Human Behaviour · doi:10.4103/jmhhb.jmhhb_125_25 · Cited by 1
Rahmani, A. H., & Sarwar, T. (2026) · Diagnostics · doi:10.3390/diagnostics16172799 · Cited by 1
“This corresponds to roughly 3% of people above 65 and up to 5% above 85 years old, with escalating economic costs from medical expenses and lost productivity [1,2,18].”
InfluentialAI Innovations in Global Health in the Context of Climate Change: Impact on Human Health Resilience
Papadopoulou, P., Apostolaki, S., Lytras, M. D., & Konstantinopoulou, S. (2024) · Advances in healthcare information systems and administration book series · doi:10.4018/979-8-3693-4402-6.ch001 · Cited by 1
Integration of AI With ML for Neuropsychological Applications
Kaur, P., Sachdeva, C., Gupta, R. K., & Jasrai, L. (2025) · Advances in psychology, mental health, and behavioral studies (APMHBS) book series · doi:10.4018/979-8-3693-9341-3.ch004 · Cited by 1
Akshaya, A., Jeevitha, S., Susendhiran, M., & Gowri, S. (2024) · International Conference on Communication and Electronics Systems (ICCES) · doi:10.1109/icces63552.2024.10860189 · Cited by 1
Torres, E. M., Huerta, M., Sacoto-Cabrera, E. J., Maldonado, S. A. A., & Ordóñez-Morales, E. F. (2025) · IEEE Technology and Engineering Management Conference - Latin America (TEMSCON LATAM) · doi:10.1109/temsconlatam65810.2025.11238777 · Cited by 1
“ML is particularly useful in the early detection of diseases, as it can analyze diverse data sources such as medical images, electronic health records, and genetic data, optimizing diagnosis and personalized treatment [5], [6].”
Chiang, H., & Chen, M. (2024) · Studies in big data · doi:10.1007/978-3-031-66842-5_6
Emotional Health Monitoring as a Key Module Within the NeuroPredict Platform
Gușatu, A.-M., Vasilevschi, A.-M., Ianculescu, M., & Petrache, M.-C. (2024) · E-Health and Bioengineering Conference (EHB) · doi:10.1109/ehb64556.2024.10805713
Qu, T., Zhao, A., Ren, T., & Kong, Y. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5144931
Artificial Intelligence applied to Biotechnology
Bordons, A. (2024) · Bionatura · doi:10.70373/rb/2024.09.04.1
Role of artificial intelligence in homeostatic disruption monitoring & Early disease detection
Kale, S., Khuspe, P. R., Phade, S., Mundphane, A., Mane, D. V., & Survase, A. B. (2025) · Indian Journal of Clinical Anatomy and Physiology · doi:10.18231/j.ijcap.2025.004
The Machine Learning Methods in Rating Cognitive State of Elderly People
Плехова, Н. Г., KABALYK, M. A., Mikhailov, A. O., & Chernenko, I. N. (2025) · Smart innovation, systems and technologies · doi:10.1007/978-981-96-1210-9_2
A Comprehensive Framework for Enterprise-Scale Data Validation and Cost Reduction on Cloud Platforms
Chintakindhi, S. K. (2025) · International Journal of Leading Research Publication. · doi:10.70528/ijlrp.v6.i1.1573
“In the end, the study’s insights build a fuller picture of how relying on data can both boost day-to-day efficiency and cut costs, making a notable addition to what we already understand [15].”
InfluentialA Fine Motor Task to Study Joint Kinematics in a Preclinical Model of Neurodegenerative Disease
Melick, A., Lukacik, D., Chawla, S., Schaefer, S. Y., Beeman, S. C., & Verpeut, J. L. (2025) · Journal of Visualized Experiments · doi:10.3791/68128
Metadata
- Authors
- Chudzik, A., Śledzianowski, A., & Przybyszewski, A. W.
- Affiliations
- Polish-Japanese Academy of Information Technology (PL)
- University of Massachusetts Chan Medical School (US)
- Corresponding author
- Przybyszewski, Andrzej W.
- Venue
- Sensors
- Publisher
- MDPI AG
- Published
- 2024-02-29
- Volume
- 24
- Issue
- 5
- Pages
- 1572
- ISSN
- 1424-8220 (ISSN-L)
- PMC
- PMC10934426
- OpenAlex
- W4392285688
- Cited by
- 122
- References
- 131
- Citations by year
- 2026: 42 · 2025: 63 · 2024: 17
- FWCI
- 9.76
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Sensors (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Health Professions › Health Information Management › Artificial Intelligence in Healthcare
- Life Sciences › Neuroscience › Cognitive Neuroscience › EEG and Brain-Computer Interfaces
- Keywords
- neurodegenerative diseases, early diagnosis, digital biomarkers, Alzheimer's disease, Parkinson's disease, eye tracking, facial expression analysis, convolutional neural networks, presymptomatic detection, data privacy, clinical validation
- MeSH terms
- Machine Learning, Alzheimer Disease, Humans, Parkinson Disease, Biomarkers, Neurodegenerative Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.